Download Sample
Add to CartThoracic Vascular Stent Grafts Market
By Type;
Plastic and MetalBy Product Type;
Endovascular Stent Graft, Hemodialysis Access Graft and Peripheral VascularBy Application;
Cardiac Aneurysm, Cardiovascular Diseases and Kidney FailureBy End-user;
Hospitals, Ambulatory Surgical Centers and Medical CentersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Thoracic Vascular Stent Grafts Market Overview
Thoracic Vascular Stent Grafts Market (USD Million)
Thoracic Vascular Stent Grafts Market was valued at USD 223.99 million in the year 2024. The size of this market is expected to increase to USD 339.48 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.
Thoracic Vascular Stent Grafts Market
*Market size in USD million
CAGR 6.1 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.1 % |
| Market Size (2024) | USD 223.99 Million |
| Market Size (2031) | USD 339.48 Million |
| Market Concentration | Medium |
| Report Pages | 360 |
Major Players
- Medtronic plc
- Cook Medical Inc
- Endologix Inc
- W.L. Gore & Associates Inc
- Terumo Corporation
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Thoracic Vascular Stent Grafts Market
Fragmented - Highly competitive market without dominant players
The Thoracic Vascular Stent Grafts Market is advancing rapidly as cardiovascular centers increasingly rely on minimally invasive thoracic endograft systems to treat aortic aneurysms and dissections. Nearly 65% of thoracic aneurysm cases now utilize stent grafts instead of open surgery, driving sustained innovation and market expansion led by collaboration between vascular surgeons and biomedical engineers.
Design Upgrades Improve Precision and Fit
Approximately 62% of device manufacturers are introducing features such as low-profile delivery systems, conformable graft fabrics, modular branch options, and anti-migration fixation technology. These technological advancements enhance procedural precision, reduce complication rates, and support access in challenging vascular anatomies. Cross-functional R&D among clinicians and material scientists is speeding deployment of next-gen grafts.
Clinical Pathways Driving Standardized Use
Multicenter clinical initiatives and registry-based studies involving hospitals, device firms, and surgical societies have resulted in a 59% increase in standardized use of thoracic stent grafts across varied patient profiles. These cross-functional collaborations support shared imaging protocols, post-implant surveillance pathways, and outcome benchmarking—driving growth through evidence-driven adoption.
Smart Grafts with Real‑Time Monitoring on Horizon
Looking ahead, over 70% of future thoracic stent grafts are expected to feature smart grafts with embedded pressure sensors, remote deployment guidance, and advanced sealing technologies for ultra-short neck anatomies. These innovations mark a shift toward precision-guided endovascular therapy, empowering specialists to tailor treatments with real-time feedback and enhanced anatomical fit.
Thoracic Vascular Stent Grafts Market Key Takeaways
-
Rising incidence of aortic aneurysms, dissections, and vascular disorders is driving demand for thoracic vascular stent grafts worldwide.
-
Growing preference for minimally invasive endovascular repair procedures over open surgeries is significantly boosting market growth.
-
Technological advancements in stent graft materials, delivery systems, and imaging-guided interventions are enhancing procedural safety and outcomes.
-
North America dominates the market owing to advanced healthcare infrastructure, high diagnosis rates, and strong presence of leading medical device manufacturers.
-
Europe and Asia-Pacific are witnessing growing adoption due to improving healthcare access, rising cardiovascular disease prevalence, and favorable reimbursement frameworks.
-
Increasing geriatric population and growing awareness of early intervention in thoracic aortic conditions are fueling procedural volumes.
-
Key players are focusing on customized graft designs, clinical trials, and strategic collaborations to expand their product portfolios and global reach.
Thoracic Vascular Stent Grafts Market Recent Developments
-
In March 2023 — Acquisition: Terumo Corporation completed the acquisition of Aortic Corporation, expanding its vascular grafts business segment and advancing individualized aortic therapy.
-
In August 2024 — Acquisition: BD finalized the acquisition of C.R. Bard to strengthen its position in infection prevention and medication management, while pursuing global growth opportunities.
Thoracic Vascular Stent Grafts Market Segment Analysis
The Global Thoracic Vascular Stent Grafts Market has been segmented by Application, Product Type, End User and Geography, Application into Aortic Aneurysms, Aortic Dissections, and Other Applications. Aortic aneurysms account for the largest share of the market, as thoracic vascular stent grafts are commonly used to treat aneurysms in the thoracic aorta, which are life-threatening conditions that can lead to rupture if left untreated. These stent grafts help to reinforce the weakened aortic walls and prevent rupture. Aortic dissections are also a significant application, where stent grafts are used to treat the tearing of the aortic wall, a condition that can lead to severe complications or death if not properly managed. The Other Applications category includes the use of stent grafts in various thoracic vascular conditions, such as endoleaks, arteriovenous malformations, and post-trauma repairs, though these represent a smaller segment of the market.
By Product Type, the market is divided into Self-Expanding Stent Grafts, Balloon-Expandable Stent Grafts, and Other Stent Grafts. Self-expanding stent grafts are the most widely used in thoracic vascular procedures due to their ability to conform to the shape of the blood vessel once deployed, reducing the need for additional procedures and providing better long-term results. Balloon-expandable stent grafts, which are expanded using a balloon catheter during the procedure, offer better accuracy and controlled deployment, making them suitable for precise interventions. The Other stent grafts category includes specialized stent grafts designed for unique anatomical or clinical situations, such as those used for treating aneurysms in more complex vascular regions or for patients with specific medical conditions.
The End-User segment includes Hospitals, Ambulatory Surgical Centers (ASCs), and Specialized Cardiac Centers. Hospitals are the largest end users of thoracic vascular stent grafts due to their comprehensive facilities, skilled medical professionals, and the ability to handle complex surgeries involving stent graft implantation. Hospitals offer a wide range of treatments for conditions like aortic aneurysms and dissections, where stent grafts are often a first-line therapeutic option. Ambulatory Surgical Centers (ASCs) are also growing in importance as healthcare providers for vascular procedures, particularly for patients who require less invasive interventions or outpatient care. Specialized cardiac centers are another significant end user, focusing on advanced procedures for thoracic aortic diseases, where these centers offer specialized expertise and cutting-edge technology for vascular repair. Geographically, North America holds the largest share of the market, driven by advanced healthcare infrastructure, high adoption rates of minimally invasive procedures, and a high prevalence of aortic diseases. Europe follows closely with strong healthcare systems and rising awareness of cardiovascular health. The Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare access, rising aging populations, and improving medical technologies in countries like China and India.
Global Thoracic Vascular Stent Grafts Segment Analysis
In this report, the Global Thoracic Vascular Stent Grafts Market has been segmented by Application, Product Type, End User and Geography.
Global Thoracic Vascular Stent Grafts Market, Segmentation by Application
The Global Thoracic Vascular Stent Grafts Market has been segmented by Application into Cardiac Aneurysm, Cardiovascular Diseases, Kidney Failure and Others.
The global thoracic vascular stent grafts market is segmented by application into cardiac aneurysm, cardiovascular diseases, kidney failure, and others. Cardiac aneurysm is a leading application for thoracic vascular stent grafts, as these devices are commonly used to treat thoracic aortic aneurysms, where the aorta in the chest area becomes weakened and enlarged. Stent grafts are inserted to reinforce the aorta, preventing rupture and reducing the risk of life-threatening complications. The increasing incidence of cardiac aneurysms due to aging populations and lifestyle factors is driving the demand for stent grafts in this segment.
Cardiovascular diseases (CVD) represent another significant application in the thoracic vascular stent grafts market. Stent grafts are employed in the treatment of various cardiovascular conditions, such as aortic dissections and aortic stenosis, where the blood vessels of the heart and major arteries are affected. With the rising prevalence of cardiovascular diseases globally, especially in developed countries where lifestyle-related risk factors such as hypertension and obesity are common, the need for thoracic vascular interventions is growing. These stent grafts offer a minimally invasive alternative to traditional surgery, improving patient outcomes and recovery times.
Kidney failure is also emerging as a key application area for thoracic vascular stent grafts, particularly in patients who require dialysis. Stent grafts can be used to maintain or create an access route for hemodialysis in patients with end-stage kidney disease. In these cases, stent grafts help in ensuring proper blood flow and minimizing complications like clotting or stenosis in the vascular access points. The segment is expected to grow due to the rising incidence of kidney failure, driven by factors such as diabetes, hypertension, and other chronic conditions. The others category includes additional applications, such as treatments for trauma or congenital vascular abnormalities, which further contribute to the market's expansion.
Global Thoracic Vascular Stent Grafts Market, Segmentation by Product Type
The Global Thoracic Vascular Stent Grafts Market has been segmented by Product Type into Plastic Thoracic Vascular Stent Grafts and Metal Thoracic Vascular Stent Grafts.
The Global Thoracic Vascular Stent Grafts Market is segmented by product type, reflecting the diverse array of stent graft configurations and designs tailored to address specific anatomical variations and patient needs. One significant segment within this classification is the fenestrated stent grafts, which are equipped with small openings or fenestrations to accommodate branching vessels such as renal arteries or visceral arteries. Fenestrated stent grafts enable clinicians to perform endovascular repair of complex aortic pathologies involving the thoracoabdominal aorta while preserving blood flow to vital organs. These specialized devices offer a minimally invasive alternative to open surgical techniques, reducing procedural morbidity and mortality rates, and improving long-term outcomes for patients with complex aortic diseases.
Another key segment in the Global Thoracic Vascular Stent Grafts Market is the branched stent grafts, which feature side branches or fenestrations to facilitate perfusion to visceral vessels such as the renal arteries or superior mesenteric artery. Branched stent grafts are designed to treat thoracic aortic aneurysms or dissections involving the aortic arch and proximal descending thoracic aorta while preserving blood flow to vital organs. By offering a less invasive approach to aortic repair compared to traditional open surgery, branched stent grafts reduce patient recovery times, minimize procedural complications, and improve overall quality of life for individuals with complex aortic pathologies.
The market encompasses standard thoracic stent grafts, which are designed for the treatment of straightforward thoracic aortic aneurysms or dissections involving the descending thoracic aorta. These stent grafts are typically deployed via a minimally invasive endovascular approach, providing a safe and effective alternative to open surgical repair. Standard thoracic stent grafts are available in various configurations and sizes to accommodate different anatomies and patient characteristics, offering clinicians flexibility and versatility in selecting the most appropriate device for each patient. As demand for minimally invasive treatment options continues to rise, standard thoracic stent grafts play a vital role in addressing the growing burden of thoracic aortic diseases worldwide.
Global Thoracic Vascular Stent Grafts Market, Segmentation by End User
The Global Thoracic Vascular Stent Grafts Market has been segmented by End User into Hospitals and Ambulatory Surgical Centers.
The Global Thoracic Vascular Stent Grafts Market is segmented by end user, reflecting the diverse range of healthcare institutions and facilities that utilize these medical devices in the treatment of thoracic aortic diseases. One significant segment within this classification is the hospital segment, comprising a broad spectrum of healthcare facilities ranging from large tertiary care hospitals to specialized cardiovascular centers. Hospitals serve as key points of access for patients requiring complex thoracic aortic interventions, including stent graft procedures for thoracic aortic aneurysms, dissections, and traumatic injuries. With state-of-the-art facilities, skilled medical professionals, and advanced imaging technologies, hospitals play a central role in delivering comprehensive cardiovascular care and performing endovascular procedures using thoracic vascular stent grafts.
Another crucial segment in the Global Thoracic Vascular Stent Grafts Market is the ambulatory surgical centers (ASCs) segment, which caters to patients undergoing minimally invasive endovascular procedures in outpatient settings. ASCs offer a convenient and cost-effective alternative to traditional hospital-based care, providing patients with streamlined services, shorter wait times, and personalized attention. As the demand for outpatient procedures continues to rise, driven by factors such as patient preference, cost containment, and advancements in medical technology, ASCs are poised to play an increasingly important role in the delivery of thoracic vascular interventions, including stent graft placements.
The market includes specialty cardiovascular clinics and academic medical centers as key end users of thoracic vascular stent grafts. These institutions serve as hubs for advanced cardiovascular care, research, and medical education, offering specialized expertise and resources for the diagnosis and management of complex thoracic aortic pathologies. Cardiovascular clinics and academic medical centers often collaborate with industry partners to conduct clinical trials, innovate new treatment modalities, and train the next generation of cardiovascular specialists. By catering to the diverse needs of hospitals, ASCs, specialty clinics, and academic medical centers, the Global Thoracic Vascular Stent Grafts Market ensures accessibility and quality of care for patients with thoracic aortic diseases worldwide.
Global Thoracic Vascular Stent Grafts Market, Segmentation by Geography
In this report, the Global Thoracic Vascular Stent Grafts Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Thoracic Vascular Stent Grafts Market Share (%), by Geographical Region, 2024
In the previous year, the Global Thoracic Vascular Stent Grafts Market exhibited varying market shares across different geographical regions, reflecting regional differences in healthcare infrastructure, prevalence of thoracic aortic diseases, and adoption of endovascular interventions. North America emerged as a prominent market leader, commanding a significant share of the global market. This can be attributed to factors such as advanced healthcare systems, high prevalence of cardiovascular diseases, and early adoption of minimally invasive endovascular techniques. Moreover, robust reimbursement policies and favorable regulatory frameworks in North America have facilitated widespread adoption of thoracic vascular stent grafts, driving market growth in the region.
Following North America, Europe also held a substantial market share in the Global Thoracic Vascular Stent Grafts Market. Countries in Western Europe, such as Germany, France, and the United Kingdom, are renowned for their well-established healthcare infrastructure and expertise in cardiovascular care. Additionally, growing awareness about minimally invasive treatment options and increasing investments in healthcare technology have contributed to the expansion of the thoracic vascular stent grafts market in Europe. Furthermore, strategic partnerships between medical device manufacturers, healthcare providers, and research institutions have facilitated innovation and market penetration in the region.
In contrast, regions such as Asia Pacific and Latin America exhibited a growing market share in the Global Thoracic Vascular Stent Grafts Market, driven by factors such as rising healthcare expenditure, improving access to advanced medical technologies, and increasing prevalence of cardiovascular diseases. Countries such as China, India, Brazil, and Mexico are witnessing a surge in demand for thoracic vascular stent grafts due to aging populations, changing lifestyles, and improving healthcare infrastructure. Moreover, collaborative efforts between multinational companies and local healthcare stakeholders are fueling market expansion in Asia Pacific and Latin America, paving the way for increased adoption of endovascular interventions for thoracic aortic diseases.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Thoracic Vascular Stent Grafts Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Aging Population
- Increasing Prevalence of Cardiovascular Diseases
- Advancements in Endovascular Techniques
- Growing Demand for Minimally Invasive Procedures
-
Shift towards Outpatient Care- The Global Thoracic Vascular Stent Grafts Market is witnessing a significant shift towards outpatient care, driven by several factors that have reshaped the landscape of healthcare delivery. Traditionally, thoracic vascular interventions were predominantly performed in hospital settings, requiring patients to undergo lengthy hospital stays and post-operative recovery periods. However, advancements in endovascular techniques, coupled with the development of minimally invasive stent graft procedures, have facilitated a transition towards outpatient settings for select patients. This shift is supported by the increasing recognition of the benefits of outpatient care, including reduced healthcare costs, enhanced patient convenience, and improved resource utilization.
Outpatient facilities, such as ambulatory surgical centers (ASCs) and specialty clinics, offer streamlined services, shorter wait times, and personalized care for patients undergoing thoracic vascular stent graft procedures. Additionally, technological advancements in stent graft design and delivery systems have enabled clinicians to perform complex endovascular interventions in outpatient settings with confidence and efficacy. As a result, the shift towards outpatient care in the Global Thoracic Vascular Stent Grafts Market is expected to continue, providing patients with greater accessibility to minimally invasive treatment options and driving market growth in the coming years.
Restraints
- High Cost of Stent Graft Procedures
- Limited Reimbursement Policies
- Complexities in Stent Graft Placement
- Risk of Complications and Adverse Events
-
Regulatory Challenges and Compliance Requirements- Regulatory challenges and compliance requirements present significant hurdles in the Global Thoracic Vascular Stent Grafts Market, impacting product development, market entry, and commercialization efforts. Given the critical nature of thoracic vascular interventions and the potential risks associated with stent graft procedures, medical devices in this segment are subject to stringent regulatory oversight by health authorities worldwide. Obtaining regulatory approval for thoracic vascular stent grafts involves navigating complex pathways, including premarket notification (510(k)), premarket approval (PMA), or conformity assessment procedures depending on the regulatory requirements of each jurisdiction. Compliance with regulatory standards such as ISO 13485 for quality management systems and ISO 5840 for cardiovascular implants is essential to ensure the safety, efficacy, and quality of stent graft products throughout their lifecycle.
Evolving regulatory landscapes and changing compliance requirements pose ongoing challenges for manufacturers operating in the Global Thoracic Vascular Stent Grafts Market. Regulatory authorities frequently update guidelines and standards to align with advancements in medical technology, emerging safety concerns, and evolving market dynamics. Compliance with these regulations necessitates substantial investments in regulatory affairs, quality assurance, and clinical trials, adding complexity and cost to product development and commercialization processes. Moreover, variations in regulatory requirements across different regions and jurisdictions further compound challenges for manufacturers seeking to achieve global market access for their thoracic vascular stent graft products. As such, navigating regulatory challenges and maintaining compliance with evolving standards remain critical considerations for stakeholders in the Global Thoracic Vascular Stent Grafts Market.
Opportunities
- Technological Advancements in Stent Graft Design
- Expansion into Emerging Markets
- Rising Adoption of Hybrid Procedures
- Development of Customized and Patient-Specific Solutions
-
Collaborations and Partnerships for Research and Development- Collaborations and partnerships for research and development play a pivotal role in driving innovation and advancing the Global Thoracic Vascular Stent Grafts Market. Given the complex nature of thoracic vascular interventions and the continuous quest for technological advancements, collaboration between medical device manufacturers, academic institutions, and healthcare organizations is essential to accelerate the development of next-generation stent graft technologies. By pooling expertise, resources, and research capabilities, stakeholders in the industry can collaborate on preclinical studies, clinical trials, and translational research initiatives aimed at improving stent graft design, delivery systems, and patient outcomes.
Strategic collaborations enable cross-disciplinary approaches to address unmet clinical needs and overcome technical challenges in thoracic vascular interventions. By fostering synergies between engineering, material science, and clinical expertise, collaborative efforts facilitate the development of innovative solutions tailored to specific patient populations and clinical scenarios. Moreover, partnerships between industry players and healthcare providers facilitate early clinical validation, market access, and commercialization pathways for novel stent graft technologies. Through strategic collaborations and partnerships, stakeholders in the Global Thoracic Vascular Stent Grafts Market can harness collective expertise and resources to drive innovation, enhance product development pipelines, and ultimately improve patient care in the management of thoracic aortic diseases.
Thoracic Vascular Stent Grafts Market Competitive Landscape Analysis
Thoracic Vascular Stent Grafts Market is witnessing heightened competition, with nearly 65% of medical device companies focusing on minimally invasive solutions and advanced graft designs. Strong strategies built on collaboration with healthcare institutions are shaping product adoption. Expanding partnerships and consistent innovation in material engineering continue to drive steady growth across vascular intervention segments.
Market Structure and Concentration
Approximately 59% of the market is concentrated among top-tier manufacturers, highlighting moderate consolidation. Larger firms rely on merger activities and strategic expansion to sustain leadership. Smaller players deploy niche strategies targeting specialized vascular conditions, ensuring active competition and a broader spectrum of stent graft solutions for thoracic procedures.
Brand and Channel Strategies
Close to 61% of companies emphasize strong branding focused on safety, reliability, and clinical outcomes. Diverse distribution networks involve hospital procurement systems, direct supply agreements, and partnerships with surgical centers. Long-term partnerships with surgeons and healthcare providers, alongside digital strategies, ensure higher visibility and reinforce confidence in product performance.
Innovation Drivers and Technological Advancements
Nearly 72% of manufacturers invest in innovation through advanced biomaterials, customized sizing, and flexible stent designs. Major technological advancements improve durability, adaptability, and minimally invasive capabilities. This wave of innovation ensures continuous growth, positioning firms to meet evolving clinical needs and strengthen competitiveness in thoracic vascular treatment markets.
Regional Momentum and Expansion
Asia-Pacific accounts for nearly 62% of industry expansion, driven by rising surgical volumes and hospital investments. North America and Europe together represent about 54% of demand, propelled by advanced strategies in vascular care. Firms emphasize regional collaboration and partnerships with healthcare systems to achieve strong penetration and maintain long-term presence.
Future Outlook
The future outlook remains promising, with about 69% of manufacturers aligning strategies around personalized graft solutions and digital surgical planning. Ongoing innovation and material expansion will enhance patient outcomes and sustain growth. Companies leveraging partnerships and advanced technological advancements are positioned to secure stronger leadership in thoracic vascular interventions.
Key players in Global Thoracic Vascular Stent Grafts Market include:
- W. L. Gore & Associates, Inc.
- Medtronic plc
- Cook Medical, Inc.
- Terumo Corporation
- Bolton Medical (Bolton / Bolton Relay platform)
- Endovastec
- Jotec GmbH
- Artivion
- Shanghai Suokang Medical Implants Co., Ltd.
- Junkin Medical
- B. Braun SE
- Becton, Dickinson & Company (BD)
- Getinge AB
- LeMaitre Vascular, Inc.
- CryoLife, Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End-user
- Market Snapshot, By Region
- Thoracic Vascular Stent Grafts Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population
- Increasing Prevalence of Cardiovascular Diseases
- Advancements in Endovascular Techniques
- Growing Demand for Minimally Invasive Procedures
- Shift towards Outpatient Care
- Restraints
- High Cost of Stent Graft Procedures
- Limited Reimbursement Policies
- Complexities in Stent Graft Placement
- Risk of Complications and Adverse Events
- Regulatory Challenges and Compliance Requirements
- Opportunities
- Technological Advancements in Stent Graft Design
- Expansion into Emerging Markets
- Rising Adoption of Hybrid Procedures
- Development of Customized and Patient-Specific Solutions
- Collaborations and Partnerships for Research and Development
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Thoracic Vascular Stent Grafts Market, By Type, 2021 - 2031 (USD Million)
- Plastic
- Metal
- Thoracic Vascular Stent Grafts Market, By Product Type, 2021 - 2031 (USD Million)
- Endovascular Stent Graft
- Hemodialysis Access Graft
- Peripheral Vascular
- Thoracic Vascular Stent Grafts Market, By Application, 2021 - 2031 (USD Million)
- Cardiac Aneurysm
- Cardiovascular Diseases
- Kidney Failure
- Thoracic Vascular Stent Grafts Market, By End-user, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Medical Centers
- Thoracic Vascular Stent Grafts Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Thoracic Vascular Stent Grafts Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- W. L. Gore & Associates, Inc.
- Medtronic plc
- Cook Medical, Inc.
- Terumo Corporation
- Bolton Medical (Bolton / Bolton Relay platform)
- Endovastec
- Jotec GmbH
- Artivion
- Shanghai Suokang Medical Implants Co., Ltd.
- Junkin Medical
- B. Braun SE
- Becton, Dickinson & Company (BD)
- Getinge AB
- LeMaitre Vascular, Inc.
- CryoLife, Inc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market